Matthew Banegas, PhD, MPH, is a health services researcher who studies the delivery, costs, and value of cancer care. His work focuses on understanding patient financial and employment-related challenges to understand the economic impacts of cancer diagnosis and treatment.
Dr. Banegas is leading the Clinic-Based Intervention to Address Financial Hardship for People with Cancer study (CAFÉ), which will provide some of the first reported trial evidence on the impact of financial navigation on the risk and severity of financial hardship from cancer. He is also the Cancer Disparities Integration co-lead for Kaiser Permanente’s National Community Oncology Research Program. His work on financial hardship is included in the National Cancer Institute Financial Toxicity and Cancer Treatment Physician Data Query (PDQ®) web resource, and the recent President’s Cancer Panel report on Promoting Value, Affordability, and Innovation in Cancer Drug Treatment.
Dr. Banegas is a steering committee member of the Social Needs Network for Evaluation and Translation (SONNET), a group created to implement Kaiser Permanente’s vision to address the social, economic and behavioral needs of its members.
Dr. Banegas received his PhD in health services research, with a concentration on cancer prevention and control, from the University of Washington/Fred Hutchinson Cancer Research Center. He completed his postdoctoral work in the Cancer Prevention Fellowship Program at the National Cancer Institute in the Division of Cancer Control and Population Sciences, Health Services and Economics Branch.
Selected Current Studies
- Clinic-Based Intervention to Address Financial Hardship for People with Cancer (NCI)
- Project Orca: Integrating Cost Communication into Clinical Care (RWJF)
- The Effectiveness, Safety, and Costs of Guideline-Concordant Lung Nodule Care (NCI)
- Work and Financial Issues among Colorectal Cancer Survivors Pilot (PCORI)
- Banegas MP, Yabroff K, O'Keefe Rosetti M, Ritzwoller DP, Fishman PA, Salloum RG, Elston Lafata J, Hornbrook MC. Medical Care Costs Associated with Cancer in Integrated Delivery Systems. Journal of National Comprehensive Cancer Network 2018 Apr;16:402-410 [PMID: 29632060]
- Banegas MP, Dickerson JF, Kent EE, de Moor JS, Virgo KS, Guy GP Jr, Ekwueme DU, Zheng Z, Nutt S, Pace L, Varga A, Waiwaiole L, Schneider J, Yabroff KR. Exploring barriers to the receipt of necessary medical care among cancer survivors under age 65 years. J Cancer Surviv 2018 Feb;12(1):28-37. [PMID: 28852970]
- Banegas MP, Guy GP, de Moor JS, Ekwueme DU, Virgo KS, Zheng J, Kent E, Nutt S, Yabroff KR. Financial Hardship among Working-age Cancer Survivors: Medical Debt and Bankruptcy. Health Affairs 2016 Jan 1;35(1):54-61. [PMID: 26733701]
- Emerson M, Banegas MP, Chawla N, Achacoso N, Alexeeff SE, Adams AS, Habel LA. Disparities in prostate, lung, breast and colorectal cancer survival and comorbidity status among urban American Indians and Alaskan Natives. Cancer Research 2017 Dec 1;77(23):6770-6776 [PMCID: PMC5728425]
- Banegas MP, John EM, Slattery ML, Gomez SL, Yu M, LaCroix AZ, Pee D, Chlebowski RT, Hines LM, Thomson CA, Gail MH. Projecting Individualized Absolute Invasive Breast Cancer Risk in U.S. Hispanic Women. Journal of the National Cancer Institute 2016 Dec 20;109(2). pii: djw215 [PMID: 28003316; PMCID: PMC5174188]
- Zheng J, Jemal A, Guy GP, Han X, Banegas MP, Li C, Ekwueme DU, Yabroff KR. Annual Medical Expenditure and Productivity Loss among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States. Journal of the National Cancer Institute 2015 Dec 24;108(5). [PMCID: PMC4849808]
- McDougall JA, Banegas MP, Wiggins C, Rajput A, Chiu VK, Flores K, Kinney A. Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors. Cancer Epidemiology, Biomarkers & Prevention 2018 Mar 28. pii: cebp.1083.2017. [PMID: 29593011, Epub 2018 Mar 28]
- Zheng Z, Han X, Guy GP Jr, Davidoff AJ, Li C, Banegas MP, Ekwueme DU, Yabroff KR, Jemal A. Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States. Cancer 2017 Apr 15;123(8):1453-1463 [PMID: 28218801]